These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11096224)

  • 41. A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis.
    Farlow MR; Alva G; Meng X; Olin JT
    Curr Med Res Opin; 2010 Feb; 26(2):263-9. PubMed ID: 19929593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.
    Potkin SG; Anand R; Fleming K; Alva G; Keator D; Carreon D; Messina J; Wu JC; Hartman R; Fallon JH
    Int J Neuropsychopharmacol; 2001 Sep; 4(3):223-30. PubMed ID: 11602028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rivastigmine: new product. No better than donepezil.
    Prescrire Int; 1999 Apr; 8(40):47-8. PubMed ID: 10848060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
    Rombouts SA; Barkhof F; Van Meel CS; Scheltens P
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):665-71. PubMed ID: 12438467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine.
    Hauber AB; Gnanasakthy A; Mauskopf JA
    Clin Ther; 2000 Apr; 22(4):439-51. PubMed ID: 10823365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease.
    Potki SG; Anand R; Hartman R; Veach J; Grossberg G
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):713-20. PubMed ID: 12188104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease.
    Wilkinson DG; Passmore AP; Bullock R; Hopker SW; Smith R; Potocnik FC; Maud CM; Engelbrecht I; Hock C; Ieni JR; Bahra RS
    Int J Clin Pract; 2002; 56(6):441-6. PubMed ID: 12166542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease.
    Grossberg GT; Olin JT; Somogyi M; Meng X
    Int J Clin Pract; 2011 Apr; 65(4):465-71. PubMed ID: 21309961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension.
    Grossberg G; Sadowsky C; Fröstl H; Frölich L; Nagel J; Tekin S; Zechner S; Ros J; Orgogozo JM
    Alzheimer Dis Assoc Disord; 2009; 23(2):158-64. PubMed ID: 19484917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
    Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
    [No Abstract]   [Full Text] [Related]  

  • 51. Rivastigmine in patients with Alzheimer's disease and concurrent hypertension.
    Erkinjuntti T; Skoog I; Lane R; Andrews C
    Int J Clin Pract; 2002 Dec; 56(10):791-6. PubMed ID: 12510954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial.
    Mowla A; Mosavinasab M; Haghshenas H; Borhani Haghighi A
    J Clin Psychopharmacol; 2007 Oct; 27(5):484-7. PubMed ID: 17873681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quetiapine and rivastigmine for agitation in Alzheimer's disease.
    Ownby RL
    Curr Psychiatry Rep; 2006 Feb; 8(1):10. PubMed ID: 16513037
    [No Abstract]   [Full Text] [Related]  

  • 54. Rivastigmine in Alzheimer's disease and Parkinson's disease dementia: an ADAS-cog factor analysis.
    Weintraub D; Somogyi M; Meng X
    Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):443-9. PubMed ID: 22009228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's type.
    Hossain M; Jhee SS; Shiovitz T; McDonald C; Sedek G; Pommier F; Cutler NR
    Clin Pharmacokinet; 2002; 41(3):225-34. PubMed ID: 11929322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of higher dose 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in patients with mild-to-moderate Alzheimer's disease.
    Grossberg G; Cummings J; Frölich L; Bellelli G; Molinuevo JL; Krahnke T; Strohmaier C
    Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):583-91. PubMed ID: 23982674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Centrally acting antiemetics mitigate nausea and vomiting in patients with Alzheimer's disease who receive rivastigmine.
    Jhee SS; Shiovitz T; Hartman RD; Messina J; Anand R; Sramek J; Cutler NR
    Clin Neuropharmacol; 2002; 25(2):122-3. PubMed ID: 11981242
    [No Abstract]   [Full Text] [Related]  

  • 58. Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease.
    Venneri A; Shanks MF; Staff RT; Pestell SJ; Forbes KE; Gemmell HG; Murray AD
    Neuroreport; 2002 Jan; 13(1):83-7. PubMed ID: 11924899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
    Farlow M
    Int Psychogeriatr; 2002; 14 Suppl 1():93-126. PubMed ID: 12636182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
    Suh DC; Arcona S; Thomas SK; Powers C; Rabinowicz AL; Shin H; Mirski D
    Drugs Aging; 2004; 21(6):395-403. PubMed ID: 15084141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.